DP600 close up

Revolutionising Digital Pathology

with the new VENTANA DP 600 slide scanner, where workflow flexibility meets high capacity slide scanning


Roche Diagnostics develops innovative products and services that address the prevention, diagnosis, monitoring, screening and treatment of diseases


About Roche Diagnostics

Doing now what patients need next.

At Roche Diagnostics we believe time is precious and we are dedicated to providing diagnostic tests and services that give people more time with their loved ones.

We are proud to be the UK’s leading provider of in vitro diagnostics tests1 and in 2020 more than 820 million Roche diagnostic tests were used by clinicians across the UK to confirm, rule out or manage health conditions including cancer, heart disease, diabetes, COVID-19, hepatitis, human papillomavirus (HPV) and many others2.

Cervical Cancer 2 ladies smiling

Case Study: Community pathway to rapidly test and treat flu

Pathway project evaluation between Innovation Agency, the Academic Health Science Network for the North West Coast (IA), Roche Products Limited and Roche Diagnostics Limited. 

Heart failure 1st image

Think Heart Failure 1st

Heart failure affects nearly 1 million people in the UK, and there are an estimated 200,000 new diagnoses each year3.  One simple test could help transform lives.


Cervical Cancer 2 ladies smiling

Let's Talk Cervical Screening

We want to open up the conversation about cervical screening - also known as a 'smear test' - providing honest views and relatable advice to help you take control of your cervical health and make an informed decision to book your appointment.

Heart failure 1st image

Shaping What Comes Next

Healthcare sustainability is a growing industry concern, challenging laboratories to do more with less. We aim to provide flexible and high quality services to support you with today’s challenges, and to prepare you for the future.


  1. Data on file
  2. Business Intelligence Team at Roche Diagnostics
  3. Conrad N, Judge A, Tran J, et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet2018;391:572-80. doi:10.1016/ S0140-6736(17)32520-5 pmid:29174292)